Yes June, calm down.
I'll say it again, if what Mdawg said is correct and that the focus is to increase R&D spend, then yes, that makes me uneasy as I would like to know how much they're increasing the spend by and what they expect the return on increased spend to be. What "assumptions" do I have? None. Merely commenting on the information at hand
- Forums
- ASX - By Stock
- SBB
- AGM Review
AGM Review, page-47
Featured News
Add SBB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online